Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127659121 | 12765912 | 1 | I | 20160826 | 0 | 20160920 | 20160920 | DIR | US-FDA-351092 | FDA-CTU | 71.00 | YR | M | N | 67.50000 | KG | 20160920 | Y | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127659121 | 12765912 | 1 | PS | FORTEO | TERIPARATIDE | 1 | Subcutaneous | N | D | 0 | |||||||||
| 127659121 | 12765912 | 2 | SS | FINASTERIDE. | FINASTERIDE | 1 | 0 | ||||||||||||
| 127659121 | 12765912 | 4 | C | DIAZEPAM. | DIAZEPAM | 1 | 0 | ||||||||||||
| 127659121 | 12765912 | 5 | SS | VITAMINS | VITAMINS | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127659121 | 12765912 | 1 | Osteoporosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127659121 | 12765912 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127659121 | 12765912 | Fatigue | |
| 127659121 | 12765912 | Lethargy | |
| 127659121 | 12765912 | Memory impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127659121 | 12765912 | 1 | 20160707 | 20160826 | 0 |